RUNX3 Facilitates Growth of Ewing Sarcoma Cells

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Journal of Cellular Physiology

• Publication date

  2014-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/jcp.24663PMID 24812032PMCID PMC4149590
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• BCL11B Is Up-Regulated by EWS/FLI and Contributes to the Transformed Phenotype in Ewing Sarcoma

  2013influential reference
• TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions

  2013influential reference
• The RUNX family in breast cancer: relationships with estrogen signaling

  2013cited by this paper
• Transcription factor RUNX1 promotes survival of acute myeloid leukemia cells.

  2013cited by this paper
• Ewing Sarcoma: Clinical State-of-the-Art

  2012cited by this paper
• RUNX3 functions as an oncogene in ovarian cancer.

  2011cited by this paper
• Runx3 is a crucial regulator of alveolar differentiation and lung tumorigenesis in mice.

  2011cited by this paper
• The role of the tumor suppressor RUNX3 in giant cell tumor of the bone.

  2011cited by this paper
• Oncogenic Partnerships: EWS-FLI1 Protein Interactions Initiate Key Pathways of Ewing's Sarcoma

  2010cited by this paper
• The Ewing's sarcoma fusion protein, EWS‐FLI, binds Runx2 and blocks osteoblast differentiation

  2010cited by this paper
• Inhibition of the transcriptional function of p53 by EWS-Fli1 chimeric protein in Ewing Family Tumors.

  2010cited by this paper
• Cancer-related ectopic expression of the bone-related transcription factor RUNX2 in non-osseous metastatic tumor cells is linked to cell proliferation and motility

  2010cited by this paper
• TEThered to Runx: novel binding partners for runx factors.

  2010cited by this paper
• Runx2 Association with Progression of Prostate Cancer in Patients: Mechanisms Mediating Bone Osteolysis and Osteoblastic Metastatic Lesions

  2009cited by this paper
• edgeR: a Bioconductor package for differential expression analysis of digital gene expression data

  2009influential reference
• Small molecule selected to disrupt oncogenic protein EWS-FLI1 interaction with RNA Helicase A inhibits Ewing's Sarcoma

  2009cited by this paper
• The TET family of proteins: functions and roles in disease.

  2009cited by this paper
• The expression of RUNX3 in colorectal cancer is associated with disease stage and patient outcome

  2009cited by this paper
• DNA Specificity Determinants Associate with Distinct Transcription Factor Functions

  2009cited by this paper
• The Oncogenic EWS-FLI1 Protein Binds In Vivo GGAA Microsatellite Sequences with Potential Transcriptional Activation Function

  2009cited by this paper
• RUNX3 Has an Oncogenic Role in Head and Neck Cancer

  2009cited by this paper
• Subnuclear targeting of the Runx3 tumor suppressor and its epigenetic association with mitotic chromosomes

  2009cited by this paper
• A small molecule blocking oncogenic protein EWS-FLI1 interaction with RNA helicase A inhibits growth of Ewing’s sarcoma

  2009cited by this paper
• Changes in Incidence and Survival of Ewing Sarcoma Patients Over the Past 3 Decades: Surveillance Epidemiology and End Results Data

  2008cited by this paper
• EWS/FLI Mediates Transcriptional Repression via NKX2.2 during Oncogenic Transformation in Ewing's Sarcoma

  2008cited by this paper
• Differentiation-Dependent Interactions between RUNX-1 and FLI-1 during Megakaryocyte Development

  2008influential reference
• Ets factors and a newly identified polymorphism regulate Fli1 promoter activity in lymphocytes.

  2008cited by this paper
• Ewing sarcoma with novel translocation t(2;16) producing an in-frame fusion of FUS and FEV.

  2007cited by this paper
• Expression profiling of EWS/FLI identifies NKX2.2 as a critical target gene in Ewing's sarcoma.

  2006cited by this paper
• RUNX3 protein is overexpressed in human basal cell carcinomas

  2006cited by this paper
• Isoforms of the Ets Transcription Factor NERF/ELF-2 Physically Interact with AML1 and Mediate Opposing Effects on AML1-mediated Transcription of the B Cell-specific blk Gene*

  2004cited by this paper
• Identification of p21 WAF1/CIP1 as a Direct Target of EWS-Fli1 Oncogenic Fusion Protein*

  2003cited by this paper
• Prostate cancer expression of runt‐domain transcription factor Runx2, a key regulator of osteoblast differentiation and function

  2003cited by this paper
• Osteoblast-related transcription factors Runx2 (Cbfa1/AML3) and MSX2 mediate the expression of bone sialoprotein in human metastatic breast cancer cells.

  2003cited by this paper
• Causal relationship between the loss of RUNX3 expression and gastric cancer.

  2002cited by this paper
• Auto-Inhibition and Partner Proteins, Core-Binding Factor β (CBFβ) and Ets-1, Modulate DNA Binding by CBFα2 (AML1)

  2000cited by this paper
• Mutual activation of Ets‐1 and AML1 DNA binding by direct interaction of their autoinhibitory domains

  1999cited by this paper
• The t(8;21) fusion product, AML-1-ETO, associates with C/EBP-alpha, inhibits C/EBP-alpha-dependent transcription, and blocks granulocytic differentiation.

  1998cited by this paper
• The t(8;21) Fusion Product, AML-1–ETO, Associates with C/EBP-α, Inhibits C/EBP-α-Dependent Transcription, and Blocks Granulocytic Differentiation

  1998cited by this paper
• Identification of novel M phase phosphoproteins by expression cloning.

  1996cited by this paper
• A second Ewing's sarcoma translocation, t(21;22), fuses the EWS gene to another ETS–family transcription factor, ERG

  1994cited by this paper
• Generation of the AML1‐EVI‐1 fusion gene in the t(3;21)(q26;q22) causes blastic crisis in chronic myelocytic leukemia.

  1994cited by this paper
• Identification of AML-1 and the (8;21) translocation protein (AML-1/ETO) as sequence-specific DNA-binding proteins: the runt homology domain is required for DNA binding and protein-protein interactions

  1993cited by this paper
• The Ewing's sarcoma EWS/FLI-1 fusion gene encodes a more potent transcriptional activator and is a more powerful transforming gene than FLI-1

  1993cited by this paper
• t(8;21) breakpoints on chromosome 21 in acute myeloid leukemia are clustered within a limited region of a single gene, AML1.

  1991cited by this paper
• t ( 8 ; 21 ) breakpoints on chromosome 21 in acute myeloid leukemia are clustered within a limited region of a single gene , AMLJ ( chromosomal translocation / cancer genetics

  year unknowncited by this paper

• RUNX2 Represses the EWS-FLI1-mediated Transcription in Ewing’s Sarcoma Cells

  2026cites this paper
• Multimodal single-cell analyses reveal distinct fusion-regulated transcriptional programs in Ewing sarcoma

  2025cites this paper
• p53 Deficiency-Dependent Oncogenicity of Runx3

  2023cites this paper
• Runt-related transcription factors in human carcinogenesis: a friend or foe?

  2023cites this paper
• The importance of fusion protein activity in Ewing sarcoma and the cell intrinsic and extrinsic factors that regulate it: A review

  2022cites this paper
• Reverse Engineering of Ewing Sarcoma Regulatory Network Uncovers PAX7 and RUNX3 as Master Regulators Associated with Good Prognosis

  2021influential citation
• Runx3 is required for oncogenic Myc upregulation in p53-deficient osteosarcoma

  2021cites this paper
• Integrated analysis of the expression, involved functions, and regulatory network of RUNX3 in melanoma.

  2021cites this paper
• Small peptide inhibitor from the sequence of RUNX3 disrupts PAK1–RUNX3 interaction and abrogates its phosphorylation-dependent oncogenic function

  2021cites this paper
• Distinct association of RUNX family expression with genetic alterations and clinical outcome in acute myeloid leukemia

  2020cites this paper
• Oncogenic RUNX3: A Link between p53 Deficiency and MYC Dysregulation

  2020cites this paper
• Elevated expression of RUNX3 co-expressing with EZH2 in esophageal cancer patients from India

  2020cites this paper
• Emerging role of RUNX3 in the regulation of tumor microenvironment

  2018cites this paper
• Ewing‐like sarcoma: An emerging family of round cell sarcomas

  2018cites this paper
• Identifying genomic biomarkers for cancer treatment

  2017cites this paper
• Molecular Pathogenesis of Bone Tumours

  2017cites this paper
• Runx3 and Cell Fate Decisions in Pancreas Cancer.

  2017cites this paper
• RUNX3 is oncogenic in natural killer/T-cell lymphoma and is transcriptionally regulated by MYC

  2017cites this paper
• The RUNX Genes as Conditional Oncogenes: Insights from Retroviral Targeting and Mouse Models.

  2017cites this paper
• Regulatory mechanisms, expression levels and proliferation effects of the FUS–DDIT3 fusion oncogene in liposarcoma

  2016cites this paper
• The cnidarian origin of the proto-oncogenes NF-κB/STAT and WNT-like oncogenic pathway drives the ctenophores (Review)

  2015cites this paper